Overview
Gabapentin for Perioperative Pain Relief in Surgical Abortion
Status:
Completed
Completed
Trial end date:
2018-03-30
2018-03-30
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
Gabapentin preoperative use for evaluation of benefit to reduce pain during and after surgical office-based abortion.Phase:
Early Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
University of Nevada, Las VegasTreatments:
Gabapentin
Criteria
Inclusion Criteria:- Women seeking surgical abortion between 5 and 23 6/7 weeks of ultrasound age.
- English or Spanish speaking
- eligible for office-based surgical pregnancy termination
Exclusion Criteria:
- present use of gabapentin or pregabalin,
- renal disease
- sensitivity or allergy to gabapentin
- Missed abortion